FDA Approves Unknown Drug — HIKMA
Hikma announced FDA approval for its ANDA 208795, a regulatory milestone expected to bolster the company’s commercial pipeline and drive future revenue growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day